-
Something wrong with this record ?
In-Silico Aided Screening and Characterization Results in Stability Enhanced Novel Roxadustat Co-Crystal
AR. Muthusamy, A. Singh, MSS. Sundaram, Y. Wagh, A. Jegorov, AK. Jain
Language English Country United States
Document type Journal Article
- MeSH
- Glycine * MeSH
- Solubility MeSH
- Publication type
- Journal Article MeSH
Roxadustat (RXD) is an approved drug substances for the treatment of renal anemia. It has poor aqueous solubility and photochemical stability. This study employs a comprehensive approach to enhance the stability and physicochemical properties RXD through coformer selection and characterization. The investigation integrates delta pKa analysis, molecular complementary assessment, molecular electrostatic potential surface analysis, and machine learning techniques to predict potential co-crystal formation and binding interactions between drug molecules and coformers. The co-crystal screening which lead to in a novel RXD-nicotinamide co-crystal (RXD-NA). Experimental characterization underscores the physical and chemical stability of the co-crystals. To elucidate the supramolecular synthons and understand the intermolecular interactions in the RXD-NA co-crystal, Hirshfeld surfaces analysis, quantum theory of atoms in molecules (QTAIM) analysis and non-covalent interaction (NCI) analysis were performed. Computational analysis of photo-isomer formation aligns with experimental observations, further enhancing our understanding of RXD-coformer interactions. RXD-NA co-crystal was found photo-chemically stable as compared to free base API drug substance. This integrated methodology provides a systematic framework for informed co-crystal design, holding promise for optimizing RXD formulations based on molecular interactions and stability considerations. Consequently, this study contributes valuable insights to the field of rational drug design and formulation optimization.
School of Basic and Applied Sciences Galgotias University India
Teva Czech Industries Branisovska 31 Ceske Budejice 37005 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014211
- 003
- CZ-PrNML
- 005
- 20240905133455.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.xphs.2023.10.024 $2 doi
- 035 __
- $a (PubMed)37875213
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Muthusamy, Anantha Rajmohan $u Department of Physical R&D, Teva API India Pvt. Ltd. Ecotech-II, Udyog Vihar, Greater Noida, Uttar Pradesh 201306, India. Electronic address: anantha.rajmohanm@teva.co.in
- 245 10
- $a In-Silico Aided Screening and Characterization Results in Stability Enhanced Novel Roxadustat Co-Crystal / $c AR. Muthusamy, A. Singh, MSS. Sundaram, Y. Wagh, A. Jegorov, AK. Jain
- 520 9_
- $a Roxadustat (RXD) is an approved drug substances for the treatment of renal anemia. It has poor aqueous solubility and photochemical stability. This study employs a comprehensive approach to enhance the stability and physicochemical properties RXD through coformer selection and characterization. The investigation integrates delta pKa analysis, molecular complementary assessment, molecular electrostatic potential surface analysis, and machine learning techniques to predict potential co-crystal formation and binding interactions between drug molecules and coformers. The co-crystal screening which lead to in a novel RXD-nicotinamide co-crystal (RXD-NA). Experimental characterization underscores the physical and chemical stability of the co-crystals. To elucidate the supramolecular synthons and understand the intermolecular interactions in the RXD-NA co-crystal, Hirshfeld surfaces analysis, quantum theory of atoms in molecules (QTAIM) analysis and non-covalent interaction (NCI) analysis were performed. Computational analysis of photo-isomer formation aligns with experimental observations, further enhancing our understanding of RXD-coformer interactions. RXD-NA co-crystal was found photo-chemically stable as compared to free base API drug substance. This integrated methodology provides a systematic framework for informed co-crystal design, holding promise for optimizing RXD formulations based on molecular interactions and stability considerations. Consequently, this study contributes valuable insights to the field of rational drug design and formulation optimization.
- 650 12
- $a glycin $7 D005998
- 650 _2
- $a rozpustnost $7 D012995
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Singh, Amit $u Department of Physical R&D, Teva API India Pvt. Ltd. Ecotech-II, Udyog Vihar, Greater Noida, Uttar Pradesh 201306, India
- 700 1_
- $a Sundaram, Meenakshi Sundaram Soma $u Department of Physical R&D, Teva API India Pvt. Ltd. Ecotech-II, Udyog Vihar, Greater Noida, Uttar Pradesh 201306, India
- 700 1_
- $a Wagh, Yogesh $u Department of Physical R&D, Teva API India Pvt. Ltd. Ecotech-II, Udyog Vihar, Greater Noida, Uttar Pradesh 201306, India
- 700 1_
- $a Jegorov, Alexandr $u Teva Czech Industries, Branisovska 31, Ceske Budejice, 37005, Czech Republic
- 700 1_
- $a Jain, Arvind Kumar $u School of Basic and Applied Sciences, Galgotias University, India. Electronic address: arvind.jain@galgotiasuniversity.edu.in
- 773 0_
- $w MED00002895 $t Journal of pharmaceutical sciences $x 1520-6017 $g Roč. 113, č. 5 (2024), s. 1190-1201
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37875213 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133449 $b ABA008
- 999 __
- $a ok $b bmc $g 2143793 $s 1226077
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 113 $c 5 $d 1190-1201 $e 20231022 $i 1520-6017 $m Journal of pharmaceutical sciences $n J Pharm Sci $x MED00002895
- LZP __
- $a Pubmed-20240725
